Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma

NCT01355679 is registered in ClinicalTrials.gov with Giselle Sholler as lead sponsor.

NCT NCT01355679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01355679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Lead sponsor
Giselle Sholler
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2011
Completion date
January 31, 2015
Enrollment
16 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma